<DOC>
	<DOCNO>NCT00434681</DOCNO>
	<brief_summary>Evaluate acceptability 24 hour new paracetamol formulation 4.8 % paediatric oral suspension child weigh 3 26 kg include limit</brief_summary>
	<brief_title>Paracetamol Oral Paediatric Suspension 4.8 % : Study Acceptability Safety .</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>The following information clinical trial provide information purpose allow patient physician initial discussion trial . This information intend complete information trial , contain consideration may relevant potential participation trial , replace advice personal physician health professional . Main criterion list hereafter : Children sex weigh 3 26 kg include limit . With fever and/or painful episode justify paracetamol treatment minimum duration 24 hour . Likely follow throughout entire study period outpatient . For informed consent sign parent legal guardian child old enough ( see chapter 12.3 ) . Presenting digestive disorder , vomit . Presenting hypersensitivity paracetamol one ingredient study product Presenting hepatocellular failure . Presenting fructose intolerance . Presenting serious concomitant disease , cancer , immune deficiency serious renal , hepatic cardiac , neurological , psychiatric metabolic disease . Presenting history significant biological anomaly . Treated KayexalateÂ® ( sodium polystyrene sulphonate ) Not cover social security regime . Whose parent incapable understanding Who come back consultation final evaluation and/or submit study constraint . Who participate another clinical study 30 day prior inclusion . Is relation investigator .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>